Feng He

3.0k total citations · 1 hit paper
55 papers, 2.1k citations indexed

About

Feng He is a scholar working on Nephrology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Feng He has authored 55 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Nephrology, 10 papers in Pulmonary and Respiratory Medicine and 9 papers in Surgery. Recurrent topics in Feng He's work include Chronic Kidney Disease and Diabetes (7 papers), Dialysis and Renal Disease Management (7 papers) and Renal and Vascular Pathologies (5 papers). Feng He is often cited by papers focused on Chronic Kidney Disease and Diabetes (7 papers), Dialysis and Renal Disease Management (7 papers) and Renal and Vascular Pathologies (5 papers). Feng He collaborates with scholars based in China, United States and Singapore. Feng He's co-authors include Ronald G. Thomas, Takeshi Iwatsubo, Xiaoying Sun, Eric Siemers, Paul Aisen, Steven Joffe, Martin R. Farlow, Gopalan Sethuraman, Rachelle S. Doody and Richard C. Mohs and has published in prestigious journals such as New England Journal of Medicine, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Feng He

49 papers receiving 2.0k citations

Hit Papers

A Phase 3 Trial of Semagacestat for Treatment of Alzheime... 2013 2026 2017 2021 2013 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Feng He China 19 725 575 313 303 200 55 2.1k
Brian M. Gilfix Canada 24 480 0.7× 638 1.1× 186 0.6× 156 0.5× 401 2.0× 59 2.1k
Jorge F. Giani United States 32 349 0.5× 976 1.7× 303 1.0× 192 0.6× 209 1.0× 73 2.7k
Ruitao Wang China 29 676 0.9× 1.1k 2.0× 151 0.5× 60 0.2× 337 1.7× 130 2.9k
Chih‐Kuang Chuang Taiwan 27 1.2k 1.7× 558 1.0× 98 0.3× 308 1.0× 114 0.6× 119 2.4k
Yuying Wang China 21 247 0.3× 418 0.7× 132 0.4× 105 0.3× 131 0.7× 85 1.4k
Shuting Zhang China 24 557 0.8× 778 1.4× 133 0.4× 55 0.2× 88 0.4× 123 2.3k
Lora J. Kasselman United States 17 364 0.5× 439 0.8× 107 0.3× 95 0.3× 187 0.9× 42 1.4k
Vita Dolžan Slovenia 33 241 0.3× 1.3k 2.2× 168 0.5× 58 0.2× 239 1.2× 210 3.7k
Tatsuo Kawai Japan 26 756 1.0× 1.2k 2.1× 203 0.6× 188 0.6× 497 2.5× 61 3.9k
Hyun Jin Kim South Korea 29 757 1.0× 1.3k 2.2× 144 0.5× 86 0.3× 385 1.9× 166 3.3k

Countries citing papers authored by Feng He

Since Specialization
Citations

This map shows the geographic impact of Feng He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng He more than expected).

Fields of papers citing papers by Feng He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feng He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng He. The network helps show where Feng He may publish in the future.

Co-authorship network of co-authors of Feng He

This figure shows the co-authorship network connecting the top 25 collaborators of Feng He. A scholar is included among the top collaborators of Feng He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feng He. Feng He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Zhaocai, Chi Zhan, Wenchuan Li, et al.. (2025). Monocytic myeloid-derived suppressor cells contribute to the exacerbation of bone destruction in periodontitis. Journal of Translational Medicine. 23(1). 217–217. 2 indexed citations
3.
Qiu, Wenjing, et al.. (2024). Rapid Hemostasis Tumor In Situ Hydrogel Vaccines for Colorectal Cancer Chemo-Immunotherapy. ACS Applied Materials & Interfaces. 16(45). 61679–61691. 2 indexed citations
4.
Li, Jianbo, Qinghua Liu, Xingji Lian, et al.. (2024). Kidney Outcomes Following Angiotensin Receptor-Neprilysin Inhibitor vs Angiotensin-Converting Enzyme Inhibitor/Angiotensin Receptor Blocker Therapy for Thrombotic Microangiopathy. JAMA Network Open. 7(9). e2432862–e2432862. 3 indexed citations
5.
Lian, Xingji, et al.. (2023). Causal links between socioeconomic status, leisure sedentary behaviours and gastro-oesophageal reflux disease: a multivariable two-sample Mendelian randomisation study. Journal of Epidemiology & Community Health. 77(7). 460–467. 5 indexed citations
6.
Luo, Qingqing, Feng He, & Jie Cao. (2021). A stromal and immune cell infiltration-based score model predicts prognosis and chemotherapy effect in colorectal cancer. International Immunopharmacology. 99. 107940–107940. 5 indexed citations
7.
Zhang, Yong, Haijun Fu, Shuhong Kuang, et al.. (2021). Exosomes derived from 3D-cultured MSCs improve therapeutic effects in periodontitis and experimental colitis and restore the Th17 cell/Treg balance in inflamed periodontium. International Journal of Oral Science. 13(1). 43–43. 126 indexed citations
8.
He, Feng, Yanrui Huang, Zhi Song, et al.. (2020). Mitophagy-mediated adipose inflammation contributes to type 2 diabetes with hepatic insulin resistance. The Journal of Experimental Medicine. 218(3). 108 indexed citations
9.
He, Feng, Ming Lei, Jun Zeng, et al.. (2020). Clinical features and risk factors for ICU admission in COVID-19 patients with cardiovascular diseases. Aging and Disease. 11(4). 763–763. 23 indexed citations
10.
11.
He, Feng, et al.. (2018). Assessment of creatinine and cystatin C-based eGFR equations in Chinese older adults with chronic kidney disease. International Urology and Nephrology. 50(12). 2229–2238. 10 indexed citations
12.
Yang, Ping, Tong Zhang, Zhuanpeng Chen, et al.. (2017). Overexpression of transcription factor activating enhancer binding protein 4 (TFAP4) predicts poor prognosis for colorectal cancer patients. Experimental and Therapeutic Medicine. 14(4). 3057–3061. 11 indexed citations
13.
Wen, Qiong, Rong Rong, Fengxian Huang, et al.. (2016). Vitamin D-Binding Protein Is a Potential Urinary Biomarker of Irbesartan Treatment Response in Patients with IgA Nephropathy. Genetic Testing and Molecular Biomarkers. 20(11). 666–673. 7 indexed citations
14.
Li, Hong, et al.. (2016). Mortality and Associated Risk Factors in Dialysis Patients with Cardiovascular Disease. Kidney & Blood Pressure Research. 41(4). 479–487. 63 indexed citations
15.
He, Feng, et al.. (2016). Evaluation of glomerular filtration rate by different equations in Chinese elderly with chronic kidney disease. International Urology and Nephrology. 49(1). 133–141. 22 indexed citations
16.
Ma, Zegang, Feng He, & Jian Xu. (2015). Quantitative assessment of the association between GAK rs1564282 C/T polymorphism and the risk of Parkinson’s disease. Journal of Clinical Neuroscience. 22(7). 1077–1080. 7 indexed citations
17.
18.
He, Feng, Ximeng Lin, Fang Xie, Yang Huang, & Ray‐Hwang Yuan. (2015). The effect of enhanced recovery program for patients undergoing partial laparoscopic hepatectomy of liver cancer. Clinical & Translational Oncology. 17(9). 694–701. 56 indexed citations
19.
He, Feng, Xianfeng Wu, Xi Xia, et al.. (2013). Pneumonia and Mortality Risk in Continuous Ambulatory Peritoneal Dialysis Patients with Diabetic Nephropathy. PLoS ONE. 8(4). e61497–e61497. 14 indexed citations
20.
He, Feng, Xi Xia, Xu Wu, Xueqing Yu, & Fengxian Huang. (2012). Diabetic retinopathy in predicting diabetic nephropathy in patients with type 2 diabetes and renal disease: a meta-analysis. Diabetologia. 56(3). 457–466. 157 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026